Adenosylhomocysteinase - Wikipedia
GeneCards.org - AHCY Gene - Adenosylhomocysteinase NLM - AHCY adenosylhomocysteinase Chicco, Davide; Sanavia, Tiziana; Jurman, ... Adenosylhomocysteinase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Vizán, Pedro; Di Croce, Luciano ... Palmer JL, Abeles RH (February 1979). "The mechanism of action of S-adenosylhomocysteinase". The Journal of Biological ... Adenosylhomocysteinase (EC 3.3.1.1, S-adenosylhomocysteine synthase, S-adenosylhomocysteine hydrolase, adenosylhomocysteine ...
RCSB PDB - 5HM8: 2.85 Angstrom Crystal Structure of S-adenosylhomocysteinase from Cryptosporidium parvum in Complex with...
2.85 Angstrom Crystal Structure of S-adenosylhomocysteinase from Cryptosporidium parvum in Complex with Adenosine and NAD. ... 2.85 Angstrom Crystal Structure of S-adenosylhomocysteinase from Cryptosporidium parvum in Complex with Adenosine and NAD.. * ... 2.85 Angstrom Crystal Structure of S-adenosylhomocysteinase from Cryptosporidium parvum in Complex with Adenosine and NAD.. ...
Recombinant Adenosylhomocysteinase
AHCY gene: MedlinePlus Genetics
sulfur compound catabolic process - Ontology Report - Rat Genome Database
Epoxide hydrolase
CoP: Co-expressed Biological Processes
Results in the O-GlcNAc Database
Exosomes Composition and Ingredients | Plurisomes™
TERF1 and AHCY Interaction - Wiki-Pi
CLADRIBINE
... is used for the treatment of hairy cell leukemia and multiple sclerosis (MS). As a purine analog, it is a synthetic anti-cancer agent that also suppresses the immune system. Chemically, it mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, which interferes with the cells ability to process DNA. It can be distinguished from other chemotherapeutic agents affecting purine metabolism in that it is cytotoxic to both actively dividing and quiescent lymphocytes and monocytes, inhibiting both DNA synthesis and repair. Cladribine injection is a potent antineoplastic agent with potentially significant toxic side effects. In MS, the novel mechanism of action of cladribine is expected to reduce inflammation, autoimmune effects and autoreactive cell damage, thereby improving the integrity of the blood-brain barrier. Thus, the effects of cladribine may target some of the key events that are central to the pathophysiology of MS ...
Selenocompound metabolism - Yeast Metabolome Database
This project is supported by the Canadian Institutes of Health Research, Canada Foundation for Innovation, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Canada, Genome Alberta, and Genome British Columbia, a not-for-profit organization that is leading Canadas national genomics strategy with $900 million in funding from the federal government ...
Jia-Yi Li - Supervised Work - Lund University
Network Portal - Gene GSU1017
Bio2Vec
Firestein, B. L.<...
Purcell, R. H., Sefik, E., Werner, E., King, A. T., Mosley, T. J., Merritt-Garza, M. E., Chopra, P., McEachin, Z. T., Karne, S., Raj, N., Vaglio, B. J., Sullivan, D., Firestein, B. L., Tilahun, K., Robinette, M. I., Warren, S. T., Wen, Z., Faundez, V., Sloan, S. A., Bassell, G. J., & 1 othersMulle, J. G., Aug 2023, In: Science Advances. 9, 33, eadh0558.. Research output: Contribution to journal › Article › peer-review ...